Annual Accounts Payable
$1.38 M
-$2.21 M-61.60%
31 December 2023
Summary:
Galera Therapeutics annual accounts payable is currently $1.38 million, with the most recent change of -$2.21 million (-61.60%) on 31 December 2023. During the last 3 years, it has fallen by -$3.77 million (-73.28%). GRTX annual accounts payable is now -73.28% below its all-time high of $5.15 million, reached on 31 December 2020.GRTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$812.00 K
-$234.00 K-22.37%
30 June 2024
Summary:
Galera Therapeutics quarterly accounts payable is currently $812.00 thousand, with the most recent change of -$234.00 thousand (-22.37%) on 30 June 2024. Over the past year, it has dropped by -$2.90 million (-78.14%). GRTX quarterly accounts payable is now -91.19% below its all-time high of $9.22 million, reached on 31 March 2021.GRTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -61.6% | -78.1% |
3 y3 years | -73.3% | -88.7% |
5 y5 years | -64.4% | -84.4% |
GRTX Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -73.3% | at low | -88.7% | at low |
5 y | 5 years | -73.3% | at low | -91.2% | at low |
alltime | all time | -73.3% | at low | -91.2% | at low |
Galera Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $812.00 K(-22.4%) |
Mar 2024 | - | $1.05 M(-23.9%) |
Dec 2023 | $1.38 M(-61.6%) | $1.38 M(-63.0%) |
Sept 2023 | - | $3.71 M(-32.7%) |
June 2023 | - | $5.52 M(-7.1%) |
Mar 2023 | - | $5.94 M(+65.8%) |
Dec 2022 | $3.58 M(-29.0%) | $3.58 M(-0.3%) |
Sept 2022 | - | $3.59 M(+0.1%) |
June 2022 | - | $3.59 M(-13.1%) |
Mar 2022 | - | $4.13 M(-18.1%) |
Dec 2021 | $5.04 M | $5.04 M(-29.8%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $7.18 M(-13.2%) |
June 2021 | - | $8.27 M(-10.3%) |
Mar 2021 | - | $9.22 M(+79.1%) |
Dec 2020 | $5.15 M(+30.4%) | $5.15 M(+28.2%) |
Sept 2020 | - | $4.01 M(-40.7%) |
June 2020 | - | $6.77 M(+1.9%) |
Mar 2020 | - | $6.64 M(+68.3%) |
Dec 2019 | $3.94 M(+2.0%) | $3.94 M(-24.4%) |
Sept 2019 | - | $5.22 M(-4.6%) |
June 2019 | - | $5.47 M(+41.5%) |
Dec 2018 | $3.87 M(+71.3%) | $3.87 M |
Dec 2017 | $2.26 M | - |
FAQ
- What is Galera Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Galera Therapeutics?
- What is Galera Therapeutics annual accounts payable year-on-year change?
- What is Galera Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Galera Therapeutics?
- What is Galera Therapeutics quarterly accounts payable year-on-year change?
What is Galera Therapeutics annual accounts payable?
The current annual accounts payable of GRTX is $1.38 M
What is the all time high annual accounts payable for Galera Therapeutics?
Galera Therapeutics all-time high annual accounts payable is $5.15 M
What is Galera Therapeutics annual accounts payable year-on-year change?
Over the past year, GRTX annual accounts payable has changed by -$2.21 M (-61.60%)
What is Galera Therapeutics quarterly accounts payable?
The current quarterly accounts payable of GRTX is $812.00 K
What is the all time high quarterly accounts payable for Galera Therapeutics?
Galera Therapeutics all-time high quarterly accounts payable is $9.22 M
What is Galera Therapeutics quarterly accounts payable year-on-year change?
Over the past year, GRTX quarterly accounts payable has changed by -$2.90 M (-78.14%)